ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

ClinicalTrials.gov ID: NCT04533880

Public ClinicalTrials.gov record NCT04533880. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 7, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction With Bone-Patellar Tendon Bone Autograft

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard for treating the bone defect with surgeons using multiple commercially available bone void fillers as well as autologous bone graft in standard practice. The purpose of the proposed study is to evaluate the effect bone-void filler on anterior knee pain following ACL reconstruction BPTB autograft.

Study identification

NCT ID: NCT04533880
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: NYU Langone Health; Other
Enrollment: 150 participants

Conditions and interventions

Conditions

Interventions

Device · Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Aug 30, 2020
Primary completion: Jul 6, 2023
Completion: Jul 6, 2023
Last update posted: Aug 12, 2024

2020 – 2023

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
NYU Langone Orthopedic Hospital	New York	New York	10003	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04533880, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 12, 2024 · Synced Sep 7, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04533880 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →